 It's here and now. A new Alzheimer's drug is coming to the market. The FDA last week approved a new drug from Eli Lilly. It clears protein clumps in the brain that are associated with Alzheimer's disease. For more, Elaine Chen is on the line. She is a reporter at our editorial partner, STAT, the health and medicine publication. Elaine, hello.